Pharmacokinetic and Pharmacodynamic Considerations When Treating Patients with Sepsis and Septic Shock

Author： De Paepe P.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.14, 2002-01, pp. : 1135-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming   Chow Andrew  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sepsis and septic shock: inching forwards

By Cohen Jonathan  

Clinical Medicine, Vol. 9, Iss. 3, 2009-06 ,pp. : 256-257

Royal College Of Physicians

Access to resources Recommend Favorite

Cytokine modulation in sepsis and septic shock

By Zanotti Sergio   Kumar Anand   Kumar Aseem  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 8, 2002-08 ,pp. : 1061-1075

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

By Müller-Lissner Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 391-401

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins

By Mahmood Iftekhar   Green Martin D.  

Clinical Pharmacokinetics, Vol. 44, Iss. 4, 2005-01 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite